IDBONY
GILD icon

Israel Discount Bank of New York’s Gilead Sciences GILD Stock Holding History

Israel Discount Bank of New York’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-170
Closed -$14K – 422
2017
Q3 		$14K Sell
170
-5,167
-97% -$395K 0.01% 380
2017
Q2 		$378K Sell
5,337
-1,790
-25% -$119K 0.3% 65
2017
Q1 		$484K Sell
7,127
-330
-4% -$23.2K 0.4% 59
2016
Q4 		$534K Buy
+7,457
New +$554K 0.48% 47

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Israel Discount Bank of New York's GILD Position: Q4 2017 in Review

Israel Discount Bank of New York sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 170 shares — an estimated $14K sold.

Israel Discount Bank of New York first reported a position in GILD in Q4 2016 and held it in 4 quarters. The position peaked at $534K in Q4 2016. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Israel Discount Bank of New York reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Israel Discount Bank of New York sold 170 Gilead Sciences shares in Q4 2017, an estimated $14K.
  • Israel Discount Bank of New York first reported a position in Gilead Sciences in Q4 2016 and held it in 4 quarters.
  • Israel Discount Bank of New York's Gilead Sciences position peaked at $534K in Q4 2016.
  • 1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Israel Discount Bank of New York's 13F filing for Q4 2017, filed 13 Feb 2018.